Image

Impact of Atelectasis on RVEDP Following Orthotropic Heart Transplantation

Impact of Atelectasis on RVEDP Following Orthotropic Heart Transplantation

Recruiting
All
Phase N/A

Powered by AI

Overview

Following orthoptopic heart transplantation (OHT), children undergo surveillance cardiac catheterizations to assess for signs of rejection including muscle biopsy as well as pressure measurements to guide post transplant treatment regiments. These procedures are done under general anesthesia which promotes lung tissue collapse (atelectasis). What is not known is the effect of atelectasis on intracardiac pressures which are a critical area of monitoring post-transplant patients for rejection.

Description

Following orthoptopic heart transplantation (OHT), children undergo surveillance cardiac catheterizations to assess for signs of rejection including muscle biopsy as well as pressure measurements. These procedures are done under general anesthesia which promotes lung tissue collapse (atelectasis). Atalectaisis is known to alter intra-thoracic pressures and cardiac loading conditions. What is not known is the effect of atelectasis on intracardiac pressures which are a critical area of monitoring post-transplant patients for rejection. Therefore, the aim of this study is to identify if atelectasis impacts the pressure measurements obtained during cardiac catheterization.

Eligibility

Inclusion Criteria:

  • Patients having undergone orthotropic heart transplantation
  • Patients requiring routine heart catheterization for post-transplant surveillance
  • General anesthesia

Exclusion Criteria:

  • Patient/parental refusal
  • Patients with suspected or known acute rejection
  • Known anti-rejection medication non-compliance
  • Patients within 1 year following heart transplant
  • Home oxygen requirement
  • Previous lung surgery (e.g., lobectomy) other than biopsy
  • Lung transplantation
  • Known pulmonary fibrosis
  • Known pulmonary hypertension (>1/2 systemic)
  • Sedation without the use of an airway device
  • Active respiratory infection -Inability to provide recruitment breaths >25mmHg -Cardiomegaly
  • Recipient/donor size mismatch

Study details
    Heart Transplant Failure
    Anesthesia

NCT06140810

Baylor College of Medicine

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.